Search Results - "Valls, María Eugenia"

Refine Results
  1. 1

    Predominant virulent IbA10G2 subtype of Cryptosporidium hominis in human isolates in Barcelona: a five-year study by Segura, Remedios, Prim, Núria, Montemayor, Michel, Valls, María Eugenia, Muñoz, Carme

    Published in PloS one (27-03-2015)
    “…Cryptosporidium infection is a worldwide cause of diarrheal disease. To gain insight into the epidemiology of the infection in a certain geographic area,…”
    Get full text
    Journal Article
  2. 2

    Characterization of digestive involvement in patients with chronic T. cruzi infection in Barcelona, Spain by Pinazo, María-Jesús, Lacima, Gloria, Elizalde, José-Ignacio, Posada, Elizabeth-Jesús, Gimeno, Fausto, Aldasoro, Edelweiss, Valls, María-Eugenia, Gascon, Joaquim

    Published in PLoS neglected tropical diseases (01-08-2014)
    “…Digestive damage due to Chagas disease (CD) occurs in 15-20% of patients diagnosed as a result of peristaltic dysfunction in some endemic areas. The symptoms…”
    Get full text
    Journal Article
  3. 3

    Acute liver failure due to visceral leishmaniasis in Barcelona: a case report by Martinez de Narvajas, Iratxe, Díaz, Alba, Bassegoda, Octavio, Carpio, Adriá, Fuster, Carla, Valls, María Eugenia, Alvarez-Martínez, Miriam J, García-Vidal, Carolina, Soriano, Alejandro, Martínez, José Antonio, Ambrosioni, Juan

    Published in BMC infectious diseases (22-10-2019)
    “…Leishmaniasis is an emerging infectious disease. Due to human migration and tourism, visceral leishmaniasis may become more common in non-endemic areas. In the…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Refractory giardiasis in Spanish travellers by Muñoz Gutiérrez, Jose, Aldasoro, Edelweiss, Requena, Ana, Comin, Ana M, Pinazo, Maria Jesús, Bardají, Azucena, Oliveira, Inés, Valls, Maria Eugenia, Gascon, Joaquim

    Published in Travel medicine and infectious disease (01-03-2013)
    “…Summary Drug failure is a common cause of symptom persistence after treatment of imported Giardia duodenalis . In this retrospective study we describe a high…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Cuánta primaquina es necesaria para erradicar los hipnozoitos de Plasmodium vivax? by Muñoz, José, Velasco, María, Alonso, David, Eugenia Valls, María, Corachán, Manuel, Gascón, Joaquim

    “…La terapia con primaquina es, hasta el momento actual, la única disponible para el tratamiento radical de la malaria por Plasmodium vivax. La dosis óptima de…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Characterization of Digestive Involvement in Patients with Chronic T. cruzi Infection in Barcelona, Spain: e3105 by Pinazo, María-Jesús, Lacima, Gloria, Elizalde, José-Ignacio, Posada, Elizabeth-Jesús, Gimeno, Fausto, Aldasoro, Edelweiss, Valls, María-Eugenia, Gascon, Joaquim

    Published in PLoS neglected tropical diseases (01-08-2014)
    “…Background Digestive damage due to Chagas disease (CD) occurs in 15-20% of patients diagnosed as a result of peristaltic dysfunction in some endemic areas. The…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    How much primaquine is needed to eradicate Plasmodium vivax hypnozoites? by Muñoz, José, Velasco, María, Alonso, David, Valls, María Eugenia, Corachán, Manuel, Gascón, Joaquim

    “…Primaquine is now the only drug available to eradicate Plasmodium vivax malaria. The optimal dose of primaquine to prevent relapses of P. vivax remains under…”
    Get full text
    Journal Article
  19. 19

    Predominant Virulent IbA10G2 Subtype of Cryptosporidium hominis in Human Isolates in Barcelona: A Five-Year Study: e0121753 by Segura, Remedios, Prim, Nuria, Montemayor, Michel, Valls, Maria Eugenia, Munoz, Carme

    Published in PloS one (01-03-2015)
    “…Background Cryptosporidium infection is a worldwide cause of diarrheal disease. To gain insight into the epidemiology of the infection in a certain geographic…”
    Get full text
    Journal Article
  20. 20

    Failure of standard treatment with praziquantel in two returned travelers with Schistosoma haematobium infection by Alonso, David, Muñoz, Jose, Gascón, Joaquim, Valls, Maria Eugenia, Corachan, Manuel

    “…A single 40 mg/kg dose of praziquantel (PZQ) continues to be the standard treatment for schistosomiasis caused by S. mansoni and S. haematobium in all clinical…”
    Get more information
    Journal Article